Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis.
Zhiwei
Z
Li
Vishal
V
Jhanji
Xiangchen
X
Tao
Haiqun
H
Yu
Wei
W
Chen
Guoying
G
Mu
D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D003432:Cross-Linking Reagents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015821:Eye Infections, Fungal / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D005260:Female; D060585:Fusariosis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D012256:Riboflavin / Q000627:therapeutic use*; D014466:Ultraviolet Rays; D014792:Visual Acuity
D000935:Antifungal Agents; D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D012256:Riboflavin